Status:
RECRUITING
Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
40-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981
Detailed Description
The aim of this pilot study is to evaluate the efficacy and safety of CKD-981 in patients with mild to moderate degenerative knee osteoarthritis who have been experiencing pain more than 8 weeks
Eligibility Criteria
Inclusion
- Patients between 40 years and 80 years old
- Patients who have experiencing knee pain more than 8 weeks
- VAS more than 40 mm
- Kellgren and Lawrence grade 2 and 3 in X' ray knee joint
Exclusion
- Previous knee surgery in affected side
- Patients with Rheumatoid arthritis, connective tissue disease, Paget's disease
- Infection of knee joint
- BMI more than 35kg/m2
Key Trial Info
Start Date :
May 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06954766
Start Date
May 12 2025
End Date
November 1 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wonju Severance Christian Hospital
Wŏnju, South Korea